We invite you to participate in a multicenter prospective observational study whose primary objective is to determine the impact of tacrolimus metabolism rate, evaluated by the concentration/dose ratio (C/D ratio), and other clinical variables on kidney function in kidney transplant patients treated with Envarsus®.
To start the study, it is necessary to conclude an online agreement. Therefore, please register and follow the instructions appearing on the computer screen.
After successful registration and signing of the electronic agreement, please log in using the data obtained during the account creation process.
Please fill out the registration form and conclude the agreement.
Biostat® company ensures the smooth course of the study and data analysis.